Abrar Abdallah Siam attended a webinar titled "From transaminases to DMD: Establishing the role of paediatric gastroenterologists and hepatologists in the identification of DMD" on September 15, 2022. The webinar was organized by PTC Therapeutics, Inc. for healthcare professionals and discussed the identification of Duchenne muscular dystrophy (DMD) by pediatric gastroenterologists and hepatologists.
Original Description:
Original Title
DMD-Sommet_Certificate-of-Attendance-v2_FORM - نسخة (1)
Abrar Abdallah Siam attended a webinar titled "From transaminases to DMD: Establishing the role of paediatric gastroenterologists and hepatologists in the identification of DMD" on September 15, 2022. The webinar was organized by PTC Therapeutics, Inc. for healthcare professionals and discussed the identification of Duchenne muscular dystrophy (DMD) by pediatric gastroenterologists and hepatologists.
Abrar Abdallah Siam attended a webinar titled "From transaminases to DMD: Establishing the role of paediatric gastroenterologists and hepatologists in the identification of DMD" on September 15, 2022. The webinar was organized by PTC Therapeutics, Inc. for healthcare professionals and discussed the identification of Duchenne muscular dystrophy (DMD) by pediatric gastroenterologists and hepatologists.
From transaminases to DMD: Establishing the role of paediatric gastroenterologists and hepatologists in the identification of DMD on 15 September 2022
Dr Clarisse Dias, MD, PhD Dr Marcelo Soares Kerstenetzky
Paediatric neurologist, Sub-investigator in Paediatric hepatologist and Head of Neuromuscular Diseases, Centre of the RARUS, Rare Disease Reference Centre, Federal University of Rio de Janeiro, Brazil Hospital Maria Lucinda, Recife, Brazil
DMD, Duchenne muscular dystrophy.
This webinar was organised and funded by PTC Therapeutics, Inc. for healthcare professionals only. GL-DMD-0703 | September 2022